In Situ Hardening Cell-Laden Constructs for Osteochondral Tissue Engineering

用于骨软骨组织工程的原位硬化细胞负载结构

基本信息

  • 批准号:
    9144318
  • 负责人:
  • 金额:
    $ 33.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-15 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The ultimate goal of this proposal is to develop an innovative and modular technology for osteochondral tissue repair comprising injectable, thermally responsive, in situ forming, and biodegradable hydrogel constructs capable of sustaining the delivery of encapsulated chondrogenic and osteogenic cell populations in a spatially directed fashion to promote native tissue regeneration. We hypothesize that a cytocompatible hydrogel system consisting of non-shrinking, injectable hydrogels with fully soluble degradation products will be formed through the combination of custom poly(N-isopropylacrylamide)-based thermogelling macromers and lysine-based crosslinking macromers that also contain sites for covalent attachment of chondroitin sulfate (CS) to enhance the integration of resultant constructs. Additionally, we hypothesize that the incorporation of poly(L-lysine) (PLL) within the thermogelling hydrogel will enhance the chondrogenic capacity of co-encapsulated articular chondrocyte and mesenchymal stem cell (AC-MSC) cocultures via the induction of developmentally relevant condensation signals. Finally, we hypothesize that a bilayered construct combining the CS-modified chondrogenic hydrogel layer with an osteogenic hydrogel layer of designer mineralizing capability will be leveraged to promote effective osteochondral tissue repair. Three Specific Aims are proposed to address these hypotheses. First, a lysine-based polyesterurethane macromer comprising a biodegradable poly(DL-lactic-co- glycolic acid) mid-block and chemically crosslinkable diamine functionalities will be developed, covalently modified with CS, combined with the thermogelling macromer and thoroughly assessed to establish structure- property relationships. Second, PLL will be incorporated into the hydrogels and its effects on the chondrogenesis of encapsulated AC-MSC cocultures will be evaluated. Further, the combined effects of PLL presentation, AC-MSC coculture, and CS-modification of hydrogel constructs on cartilage tissue integration will be also evaluated ex vivo. Third, the hydrogels developed in Specific Aim 1 and optimized for chondrogenic potential in Specific Aim 2 will be merged with hydrogel formulations with high mineralizing capability to yield bilayered hydrogel constructs comprising chondrogenic and osteogenic layers for the effective repair of osteochondral defects. The potential synergistic effects of encapsulated cells in the osteogenic and chondrogenic layers with PLL delivery will be evaluated in vitro and in vivo to determine the most effective configuration for osteochondral tissue repair in a well-established rabbit osteochondral defect model. The proposed system will address persisting significant challenges associated with osteochondral defect repair by enabling stable integration of the construct with the surrounding native cartilage tissue through a highly modular two-component design, while promoting the chondrogenic and osteogenic differentiation of respective cell populations delivered to effect both cartilage and bone regeneration, respectively.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

ANTONIOS G. MIKOS的其他基金

In Situ Hardening Cell-Laden Constructs for Osteochondral Tissue Engineering
用于骨软骨组织工程的原位硬化细胞负载结构
  • 批准号:
    9326813
    9326813
  • 财政年份:
    2015
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
In Situ Hardening Cell-Laden Constructs for Osteochondral Tissue Engineering
用于骨软骨组织工程的原位硬化细胞负载结构
  • 批准号:
    9761989
    9761989
  • 财政年份:
    2015
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
In Situ Hardening Cell-Laden Constructs for Osteochondral Tissue Engineering
用于骨软骨组织工程的原位硬化细胞负载结构
  • 批准号:
    9036736
    9036736
  • 财政年份:
    2015
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
Flow Perfusion Bioreactor Fabrication of Bioactive Polymer/ECM Hybrid Constructs
生物活性聚合物/ECM 混合结构的流动灌注生物反应器制造
  • 批准号:
    8053261
    8053261
  • 财政年份:
    2009
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
Flow Perfusion Bioreactor Fabrication of Bioactive Polymer/ECM Hybrid Constructs
生物活性聚合物/ECM 混合结构的流动灌注生物反应器制造
  • 批准号:
    8234157
    8234157
  • 财政年份:
    2009
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
Flow Perfusion Bioreactor Fabrication of Bioactive Polymer/ECM Hybrid Constructs
生物活性聚合物/ECM 混合结构的流动灌注生物反应器制造
  • 批准号:
    7635107
    7635107
  • 财政年份:
    2009
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
Flow Perfusion Bioreactor Fabrication of Bioactive Polymer/ECM Hybrid Constructs
生物活性聚合物/ECM 混合结构的流动灌注生物反应器制造
  • 批准号:
    7799085
    7799085
  • 财政年份:
    2009
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
Flow Perfusion Bioreactor Fabrication of Bioactive Polymer/ECM Hybrid Constructs
生物活性聚合物/ECM 混合结构的流动灌注生物反应器制造
  • 批准号:
    8449293
    8449293
  • 财政年份:
    2009
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
In Situ Hardening Cellular Constructs for Craniofacial Bone Regeneration
用于颅面骨再生的原位硬化细胞结构
  • 批准号:
    8217161
    8217161
  • 财政年份:
    2008
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
In Situ Hardening Cellular Constructs for Craniofacial Bone Regeneration
用于颅面骨再生的原位硬化细胞结构
  • 批准号:
    7603095
    7603095
  • 财政年份:
    2008
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Catheter-injectable system for local drug delivery after myocardial infarct
用于心肌梗死后局部给药的导管注射系统
  • 批准号:
    10722614
    10722614
  • 财政年份:
    2023
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
Epigenetically regulated stemness program and stem cell niche as targets in pediatric DIPG
表观遗传调控的干细胞程序和干细胞生态位作为儿科 DIPG 的目标
  • 批准号:
    10635435
    10635435
  • 财政年份:
    2023
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
Characterization of Ionotropic Receptors in Mating and Blood Feeding in Anopheles mosquitoes
按蚊交配和吸血中离子型受体的表征
  • 批准号:
    10736638
    10736638
  • 财政年份:
    2023
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别:
Reactive aldehydes and alcohol misuse in lung infections
肺部感染中的活性醛和酒精滥用
  • 批准号:
    10581148
    10581148
  • 财政年份:
    2023
  • 资助金额:
    $ 33.36万
    $ 33.36万
  • 项目类别: